2022 APAGE-ISMIVS HIFU Series Webinars
EP4
Episode 4 kicked off on August 18 is a successful conclusion to the 2022 APAGE-ISMIVS Series of HIFU Webinar that provided clinical application scenarios and up-to-date research insights for gynaecologists worldwide to explore more minimally invasive and noninvasive therapies.
For the 2022 Series, we presented 4 webinars focusing on the management of 4 different gynaecological disorders to nearly 500 global attendees. We appreciate all the guests for taking the time with us and sincerely hope the lectures dedicated by our speakers will somehow bring innovative ideas to you.
Prof. David Cranston, the President of ISMIVS and the Emeritus Associate Professor of Surgery in the Nuffield Department of Surgical Science, University of Oxford, said in his opening speech that ISMIVS and APAGE have been working together to break the geographical barriers in the post-pandemic era, taking the HIFU series as a starting point to promote the popularization and development of minimally invasive and noninvasive medicine, and have made remarkable achievements in scientific education, academic exchange and global development. He looked forward to communicating with fellow physicians in the near future on the advances in this field.
Prof. Rudy Leon De Wilde, Head of the University Clinic for Gynecology of the Faculty of Medicine and Health Science, Carl von Ossietzky University, Oldenburg, Germany, first introduced the evolution of surgery from open surgery based on anatomy to minimally invasive surgery based on laparoscopic technique, then to extracorporeal noninvasive procedure based on imaging anatomy. He elaborated on clinical and social advantages of HIFU including no incisions, shorter hospital stay, uterine function preserved, life quality improvement, no scars, etc. He also indicated adverse events that might occur in the near-field region after HIFU, and concluded that in future, adenomyosis treatment by HIFU would be qualified to give patients a chance to protect their uterus.
Dr. Sevellaraja Supermaniam (S. Selva)， Head of the IVF Centre and HIFU Centre at a private hospital in Melaka, Malaysia, shared treatment options for infertility patients with adenomyosis based on his rich clinical experience, and case studies of 3 types of adenomyosis that keen on pregnancy requiring HIFU therapy, including patients who have frozen embryo, keen on spontaneous pregnancy, and still single. He concluded that for women with adenomyosis who have difficulty in conceiving especially after failed IVF, HIFU is a good option to shrink the adenomyosis before frozen embryo transfer.
Dr. Hsin-Hong Kuo, Deputy Secretary General, APAGE, first introduced the pathological mechanism and classification of adenomyosis, as well as applicable treatment options, then shared the surgery video of adenomyomectomy under laparoscopy to detailed the skills and tricks during the surgery.
+86 23 67886199
